Expedient liquid chromatographic method with fluorescence detection for montelukast sodium in micro-samples of plasma

J Chromatogr B Biomed Sci Appl. 2001 Apr 25;754(2):527-31. doi: 10.1016/s0378-4347(01)00025-1.

Abstract

This study describes an expedient assay for the analysis of the asthma medication, montelukast sodium (Singulair, MK-0476), in human plasma samples. After a simple extraction of the plasma, the drug and internal standard, quinine bisulfate, were measured by HPLC. The chromatographic system consisted of a single pump, a refrigerated autosampler, a C8 4-microm particle size radial compression cartridge at 40 degrees C and a fluorescence detector with the excitation and emission wavelengths set at 350 and 400 nm, respectively. The mobile phase which was delivered at 1.0 ml/min, was prepared by adding 200 ml of 0.025 M sodium acetate, pH adjusted to 4.0 with acetic acid, to 800 ml of acetonitrile, with 50 microl triethylamine. With a run time of only 10 min per sample, this assay had an overall recovery of >97% with a detection limit of 1 ng/ml. The inter- and intra-run relative standard deviations at 0.05, 0.2 and 1.0 microg/ml were all <9.2%, while the analytical recovery at the same concentrations were within 7.7% of the amount added.

MeSH terms

  • Acetates / blood*
  • Anti-Asthmatic Agents / blood*
  • Asthma / blood*
  • Chromatography, High Pressure Liquid / methods*
  • Cyclopropanes
  • Fluorescence
  • Humans
  • Light
  • Quality Control
  • Quinolines / blood*
  • Reference Standards
  • Sulfides

Substances

  • Acetates
  • Anti-Asthmatic Agents
  • Cyclopropanes
  • Quinolines
  • Sulfides
  • montelukast